Raleigh NC (PRWEB) January 15 2014 DTS Language Services Inc . is pleased to announce an enhancement to its Online Web Portal for Life Science organizations who need document translations. Clients will now have the ability to specify

DTS Language Services, Inc. is pleased to announce an enhancement to its Online Web Portal for Life Science organizations who need document translations. Clients will now have the ability to specify the subject matter of their documents in advance with a selection of nearly 50 life science sub-domains. This will help reduce time-to-delivery of translations, often a critical factor in clinical and scientific fields, and decrease the likelihood of error.

“All translations are inherently time-sensitive by their very nature, due to the critical decision making and approval processes which depend on fast turn-arounds,” said Duncan Shaw, President of DTS. “Because we will have a faster understanding up-front of the given domain requirement, we will be able to more quickly identify those translators who are best qualified, and deliver translations even faster.”

Additionally, for organizations who have on-going document translation needs, this tool will help strengthen document version control practices by improving consistency. “If several direct report employees have recurring translation needs, now there will be a streamlined, consistent approach for all of them. This will improve decision making, communication, budgeting, and accountability for everyone,” Shaw said.

In 2007, DTS began a partnership with German technology developer Plunet GmbH to offer an easy to use customer web portal aimed at improving translation efficiencies while reducing translation costs and delays. “We offer free training to use our online portal with the end goals of making translations go faster, easier, and as pain-free as possible,” Shaw said.

Most CRAs, Project Managers, and other medical translation buyers do not have the time to be burdened with translation headaches, because document translations are only one facet of their responsibilities. Now, whether a translation need is part of a clinical trial, a new medical device breakthrough, or biotechnology research, the exact needs can be easily, quickly, and consistently identified by any employee, and then shared across company departments.

For further information, or to request a capabilities demonstration, please contact Duncan Shaw at (800) 524-0722 or dshaw(at)dtstranslates(dot)com.

About DTS Language Services, Inc.
DTS Language Services, Inc., offers corporate document translation services in over 50 language directions. Since 1973, the company has performed tens of thousands of translations for over 500 organizations spanning the globe. DTS is located near world renowned Research Triangle Park, North Carolina. Unlike many language services which offer “any language, any field”, DTS specializes in translating clinical, medical, and scientific documents with translators who bring real-world experience as scientists, clinicians, and physicians among other key roles. For more information, please visit http://www.dtstranslates.com

(Date:12/8/2016)... CA (PRWEB) , ... December 08, 2016 , ... Lajollacooks4u, ... was a banner year for team building events, new program offerings and company expansion. ... it expanded earlier this year to include groups of over 30 people. Ever since, ...

(Date:12/8/2016)... Biotheranostics today announced that new data will ... Cancer Index (BCI) in identifying which patients with ... for disease recurrence and might benefit from extended ... advancing the understanding of the value of BCI ... inform decisions related to patient treatment. These data ...

(Date:11/21/2016)... Lithuania , Nov. 21, 2016 ... and object recognition technologies, today announced that the ... smart cards was submitted for the NIST ... successfully passed all the mandatory steps of the ... evaluation is a continuing test of fingerprint templates ...

(Date:11/15/2016)... Nov. 15, 2016 Synthetic Biologics, Inc. (NYSE ... focused on the gut microbiome, today announced the ... shares of its common stock and warrants to ... a price to the public of $1.00 per ... Biologics from the offering, excluding the proceeds, if ...